Cargando…
Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective
The global incidence of coronavirus disease 2019 (COVID-19) continues to increase despite health care efforts. The disease is caused by coronavirus 2 with high transmission and mortality rates. Little is known about the management of COVID-19 in advanced liver disease. The aim of work was to propose...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739155/ https://www.ncbi.nlm.nih.gov/pubmed/33362383 http://dx.doi.org/10.3748/wjg.v26.i46.7272 |